DHR Health Institute for Research and Development Acquires Mobile Research Unit to Treat COVID-19 Patients

Mobile unit to help identify and evaluate potential treatments for non-hospitalized adults with COVID-19

Translate to Spanish or other 102 languages!

Delievery of the Mobile Research Unit

Mega Doctor News

- Advertisement -

Edinburg, Texas – DHR Health Institute for Research and Development announces the arrival of the National Institutes of Health (NIH) Sponsored Mobile Research Unit.  DHR Health Institute for Research and Development is one of nine to be granted a unit by the NIH, allowing the institute to continue their mission to treat COVID-19 patients in the Rio Grande Valley. 

“We are extremely excited to partner with NIH in this initiative and to be only 1 of 9 sites in the US that has been granted by NIH with such capacity-building initiative,” said Sohail Rao, executive vice president, DHR Health and president and CEO DHR Health Institute. “The Mobile Research Unit will be used to enroll thousands of patients and volunteers in large scale clinical trials testing a variety of investigational vaccine, monoclonal antibodies and drugs intended to protect people from COVID-19 and/or treat them for acute and chronic complications of COVID-19”

Through the acquirement of the Mobile Research Unit, DHR Health Institute for Research and Development will expand the capacity to conduct innovative clinical trials that would benefit the residents of the Rio Grande Valley and treat them for chronic complications of COVID-19.  The 38×11.5 unit, that features a nurse practitioner, research nurse coordinator, driver/coordinator, three exam rooms and a lobby, will have access to enroll thousands of patients and volunteers in large clinical trials, testing a variety of investigational vaccines, monoclonal antibodies, and drugs intended to protect people from COVID-19. 

- Advertisement -

The DHR Health Institute for Research and Development is committed to providing access to innovative and advanced clinical care for patients in the Rio Grande Valley and currently has four clinical trials that will be initiated in the mobile unit immediately while other trials are being negotiated.  Committed to enrolling individuals most impacted by COVID-19, DHR Health Institute for Research and Development will work closely with the community to make participation in the trial available to those who qualify for clinical research.  In addition to a modest stipend, transportation services are also available for patients who would like to participate.

For more information about participating in a study, please call DHR Health Institute for Research and Development at 956-362-2393 or visit DHRResearch.org

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Recognizes November as “National Hospice and Palliative Care” Month

DHR Health is pleased to recognize November as “National Hospice and Palliative Care Month.”  As we highlight National Hospice and Palliative Care Month, let us remember that healthcare is not solely about treating diseases but also about care for people at end of life.

STHS Heart Earns Healthgrades Five-Star Rating for Pacemaker Procedures

Healthgrades, the leading online resource for information about physicians and hospitals, has named STHS Heart a Five-Star Recipient for Pacemaker Procedures in 2027 for the second consecutive year, recognizing the facility's superior clinical outcomes and commitment to patient care.

Renaissance Cancer Foundation to Host 16th Anniversary “Viva la Vida” Gala, Nov. 21st

 The Renaissance Cancer Foundation, a non-profit organization of DHR Health, is excited to announce its 16th anniversary gala, featuring Miami’s premier party band, Extasy. The fundraising event is set to take place on November 21, 2026, at the Edinburg Conference Center at Renaissance, located at 118 Paseo Del Prado in Edinburg.

Op-ED: More than a ‘Smokers Disease’: Why Lung Cancer Awareness Must Become a Priority

In the wake of Pope Leo XIV’s recent lung cancer diagnosis, public interest in the disease has surged, underscoring the important role prevention and early detection play in achieving better outcomes.
- Advertisement -